Focus Stocks
Biogen Idec to Present at the Leerink Swann Global Healthcare Conference
Published on Wednesday, 08 February 2012 16:14 Written by TradersHuddle Staff
WESTON, Mass.-( Business Wire )-Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Leerink Swann Global Healthcare Conference will be webcast live on Wednesday, February 15, 2012 at 8:30 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investor Relations section (www.investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates nearly $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.
Related Articles
- New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine
- Trade Alert - Biogen Idec at New Highs
- Biogen Idec @ Year Highs
- US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review
- Biogen Idec Bulls in Charge
- Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference
- Stock Futures Mixed amid Earnings. Stocks to Watch: APC, AAPL, BAC, BIIB, BP, EMR, F, MAS, PFE
- Biogen Idec Increases Revenue 7% to $1.3 Billion in the First Quarter
- A 52 Week High for Biogen Idec, will it Hold?
- New TYSABRI Data Presented at 64th Annual AAN Meeting Highlight Biogen Idec & Elan Commitment to Improving Outcomes in Multiple Sclerosis
Related Partner Headlines
- Biogen Idec Inc (BIIB): Today's Featured Health Care Loser - TheStreet.com
- Biogen Idec Reaches New 52-Week High (BIIB) - TheStreet.com
- Biogen Idec Inc (BIIB): Today's Featured Health Care Winner - TheStreet.com
- Biogen Idec Announces US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review - Benzinga
- Biogen Idec Inc (BIIB): Today's Featured Health Care Winner - TheStreet.com
- UPDATE: Jefferies Raises PT to $154 on Biogen Idec; Strong MS Dynamics - Benzinga
- Financial Breakfast: Morning News Summary for May 1, 2012 - Benzinga
- 6 Stocks Hit 52-Week Highs: PFE, LMT, VAL, BIIB, MSG, BYI - TheStreet.com
- Biogen Idec Reaches New 52-Week High (BIIB) - TheStreet.com
- Biogen Idec Stock Hits New 52-Week High (BIIB) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012 -
Diamond Value Management strategy and corporate turnaround leverages Rockwell repositioning









